Aurogen's technology involves breakthrough medicine that can reduce health care costs. The lead product is a newly patented pharmaceutical treatment for diabetic neuropathy. Plans for product manufacture and development, including drafts of phase I/II clinical trials, have been prepared. Aurogen's neurotrophic hormones can act across the blood-brain barrier (BBB) to treat various brain disorders. Supportive animal and clinical data are available for both inventions
